The influence of glatiramer acetate on dendritic cells mediated Th17-immune response in multiple sclerosis.

被引：0
|
作者：
Sharanova, S. [1 ]
Melnikov, M. [1 ]
Rogovskii, V. [2 ]
Sviridova, A. [3 ]
Boyko, A. [3 ]
Pashenkov, M. [4 ]
机构：
[1] Pirogov Russian Natl Res Med Univ, Dept Neurol Neurosurg & Med Genet, Moscow, Russia
[2] Pirogov Russian Natl Res Med Univ, Dept Mol Pharmacol & Radiobiol, Moscow, Russia
[3] Fed Ctr Cerebrovasc Pathol & Stroke, Dept Neuroimmunol, Moscow, Russia
[4] Inst Immunol, Lab Clin Immunol, Moscow, Russia
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2020年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPR3086
引用
收藏
页码：469 / 469
页数：1
相关论文
共 50 条
  • [31] T-cell mediated reactions to glatiramer acetate in patients with multiple sclerosis
    Mayorga, C.
    Torres, M.
    Gomez, F.
    Gomez, E.
    Blazquez, A.
    Sanchez, M.
    Guerrero, M.
    Melendez, L.
    Blanca, M.
    ALLERGY, 2011, 66 : 265 - 265
  • [32] Impact of Glatiramer Acetate on B Cell-Mediated Pathogenesis of Multiple Sclerosis
    Kuerten, Stefanie
    Jackson, Leila J.
    Kaye, Joel
    Vollmer, Timothy L.
    CNS DRUGS, 2018, 32 (11) : 1039 - 1051
  • [33] Impact of Glatiramer Acetate on B Cell-Mediated Pathogenesis of Multiple Sclerosis
    Stefanie Kuerten
    Leila J. Jackson
    Joel Kaye
    Timothy L. Vollmer
    CNS Drugs, 2018, 32 : 1039 - 1051
  • [34] Influence of Genetic Polymorphisms on Clinical Outcomes of Glatiramer Acetate in Multiple Sclerosis Patients
    Zarzuelo-Romero, Maria Jose
    Perez-Ramirez, Cristina
    Cura, Yasmin
    Carrasco-Campos, Maria Isabel
    Marangoni-Iglecias, Luciana Maria
    Ramirez-Tortosa, Maria Carmen
    Jimenez-Morales, Alberto
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (10):
  • [35] Predictive cytokine biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis
    Valenzuela, R. M.
    Kaufman, M.
    Balashov, K. E.
    Ito, K.
    Buyske, S.
    Dhib-Jalbut, S.
    JOURNAL OF NEUROIMMUNOLOGY, 2016, 300 : 59 - 65
  • [36] Potential biomarkers of disease activity and response to treatment with glatiramer acetate in multiple sclerosis
    Kruszewski, Adam M.
    Rao, Gautam K.
    Tatomir, Alexandru
    Hewes, Daniel
    Tegla, Cosmin A.
    Cudrici, Cornelia D.
    Nguyen, Vingh
    Royal, Walter, III
    Bever, Christopher
    Rus, Violeta
    Rus, Horea
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 10 - 11
  • [37] The role of dopamine in modulation of Th-17 immune response in multiple sclerosis
    Melnikov, Mikhail
    Belousova, Olga
    Murugin, Vladimir
    Pashenkov, Mikhail
    Boyko, Alexey
    JOURNAL OF NEUROIMMUNOLOGY, 2016, 292 : 97 - 101
  • [38] Interferon-β and glatiramer acetate act differently in multiple sclerosis at the dendritic cell level:: Basis for improved multiple sclerosis therapy
    Huang, YM
    Hussien, Y
    Söderström, M
    Sanna, A
    Link, H
    ANNALS OF NEUROLOGY, 2001, 50 (03) : S25 - S25
  • [39] Multiple sclerosis: Phenotype of cerebrospinal fluid T cells specific for glatiramer acetate
    Holmoy, Trygve
    Skorstad, Gjertrud
    Hestvik, Anne Lise K.
    Vartdal, Frode
    NEUROLOGY, 2007, 68 (12) : A19 - A20
  • [40] Statins affect Th-17-mediated autoimmune response in multiple sclerosis
    Zhang, Xin
    Speer, Danielle
    Markovic-Plese, Silva
    JOURNAL OF NEUROIMMUNOLOGY, 2008, 203 (02) : 141 - 142
12345